Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Utah House passes 'right to try' bill allowing some terminal patients to seek investigational drugs
Summary
The House adopted a third substitute of HB 94 to let terminally ill patients seek investigational drugs that have completed FDA phase‑1 testing, add liability protections for providers, and place limited insurance conditions; after extended debate the bill passed 72–1 and will go to the Senate.
Representative Dan McCay (note: sponsor identified in debate as Representative Frower in this transcript) led floor action to uncircle and adopt a third substitute for House Bill 94, described on the floor as a 'right to try' measure to allow terminally ill patients access to investigational drugs that have completed Food and Drug Administration (FDA) phase‑1 testing. The sponsor told colleagues the bill aims to give patients who have exhausted conventional options “a glimmer of hope” and to avoid lengthy FDA compassionate‑use delays that can outlast a patient's remaining time.
The bill’s…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
